The regression analysis in MDA5+ DM-ILD patients showed that the poor prognosis was associated with low CD3+CD8+ and low CD3+CD19+ levels (HR were 3.81 and 3.43, respectively) (Table 5). The gene discussed is CD19; the disease is interstitial lung disease.